Abstract Objective Whether cyclosporine A (CsA) is a risk factor of kidney injury after
allogeneic hematopoietic stem cell transplantation (allo-HSCT) has not been determined …

Background Acute kidney injury (AKI) is common after hematopoietic cell transplantation
(HCT) and is associated with poorer outcomes. Risk factors for AKI after pediatric HCT are …

Aims: The aim of this study was to identify risk factors associated with acute kidney injury
(AKI) after hematopoietic stem cell transplantation (HSCT) by systematically reviewing the …

Acute kidney injury (AKI) is a frequent complication following allogeneic hematopoietic stem
cell transplantation (allo-HSCT), but few studies have focused on AKI treated with kidney …

Simple Summary The incidence and prevalence of hematologic malignancies are
increasing throughout the world and hematopoietic stem cell transplant contributes to …

Background Acute kidney injury (AKI) is a common complication of hematopoietic stem cell
transplantation (HSCT) with increased mortality and morbidity. Understanding the risk …

Background Autologous hematopoietic stem cell transplant plays an important role in
multiple myeloma (MM) treatment. Increasing incidence of MM and growing awareness of …

The occurrence of secondary neoplasms in adult patients treated with chemotherapy in
childhood is not uncommon. Prior chemotherapy is found to be an independent risk factor for …

1. Background: Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) is often
complicated by Acute Kidney Injury (AKI) and has been increasingly used in patients with …

Allogeneic hematopoietic stem cell transplantation (allo-HSCT), as a curative therapy, was
widely used for hematological diseases. Although the intense alloreactivity had been …